BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2690164)

  • 1. Rebound withdrawal reactions due to clomipramine.
    Diamond BI; Borison RL; Katz R; DeVeaugh-Geiss J
    Psychopharmacol Bull; 1989; 25(2):209-12. PubMed ID: 2690164
    [No Abstract]   [Full Text] [Related]  

  • 2. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine for obsessive compulsive disorder.
    Med Lett Drugs Ther; 1988 Nov; 30(778):102-4. PubMed ID: 3050411
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of clomipramine in childhood obsessive compulsive disorder.
    Flament MF; Rapoport JL; Kilts C
    Psychopharmacol Bull; 1985; 21(1):150-2. PubMed ID: 3885292
    [No Abstract]   [Full Text] [Related]  

  • 6. [A double-blind trial of chlorimipramine and doxepin in obsessive-compulsive neurosis].
    Cui YH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):279-81. PubMed ID: 3556094
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison.
    Leonard H; Swedo S; Rapoport JL; Coffey M; Cheslow D
    Psychopharmacol Bull; 1988; 24(1):93-5. PubMed ID: 3290954
    [No Abstract]   [Full Text] [Related]  

  • 8. [A cross-over treatment of obsessive-compulsive neurosis with imipramine and chlorimipramine].
    Lei BS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):275-8. PubMed ID: 3556093
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical controlled trial of chlorimipramine in adolescents with obsessive-compulsive disorder.
    Rapoport J; Elkins R; Mikkelsen E
    Psychopharmacol Bull; 1980 Jul; 16(3):61-3. PubMed ID: 6996027
    [No Abstract]   [Full Text] [Related]  

  • 10. Clomipramine in obsessional disorders: a cautionary tale.
    Morstyn R
    Aust N Z J Psychiatry; 1988 Jun; 22(2):190-4. PubMed ID: 3401188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine in obsessive compulsive disorder.
    Lee S
    J Clin Psychiatry; 1991 Apr; 52(4):183-5. PubMed ID: 2016256
    [No Abstract]   [Full Text] [Related]  

  • 13. Obsessional compulsive neurosis--a method of treatment.
    Perera HV
    Ceylon Med J; 1981 Dec; 26(4):169-72. PubMed ID: 7348612
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic effects of anafranil in obsessive compulsive disorder. Recent clinical findings.
    Katz RJ; Landau P; DeVeaugh-Geiss J; Hakkarainen H
    Prog Clin Biol Res; 1990; 361():489-93. PubMed ID: 2149765
    [No Abstract]   [Full Text] [Related]  

  • 15. Clomipramine in phobic and obsessional states: preliminary report.
    Silva FR; Wijewickrama HS
    N Z Med J; 1976 Jul; 84(567):4-6. PubMed ID: 1067503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
    Ackerman DL; Greenland S; Bystritsky A; Morgenstern H; Katz RJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):247-54. PubMed ID: 7962680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J; Pecknold JC; van den Steen N; Engelsmann F
    Prog Neuropsychopharmacol; 1981; 5(3):257-62. PubMed ID: 7022517
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 20. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.